Interplay between glycogen synthase kinase-3β and tau in the cerebellum of Hsp27 transgenic mouse

Journal of Neuroscience Research

Volumn 89, Issue 8, 2011, Pages 1267-1275

  Wang, Shan ^a,b   Toth, Melinda Erzsebet ^c   Bereczki, Erika ^a   Santha, Miklos ^c   Guan, Zhi Zhong ^a,d   Winblad, Bengt ^a   Pei, Jin Jing ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Glycogen synthase kinase 3; Heat shock protein 27; Transgenic mice

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 27; PHOSPHOPROTEIN PHOSPHATASE 2A; S6 KINASE; TAU PROTEIN;

ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DEMETHYLATION; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE;

ANIMALS; CEREBELLUM; GLYCOGEN SYNTHASE KINASE 3; HSP27 HEAT-SHOCK PROTEINS; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; TAU PROTEINS;

EID: 79957838856     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22660     Document Type: Article

References (59)

1. Akbar MT, Lundberg AM, Liu K, Vidyadaran S, Wells KE, Dolatshad H, Wynn S, Wells DJ, Latchman DS, de Belleroche J. 2003. The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J Biol Chem 278: 19956-19965.
2. Becker J, Craig EA. 1994. Heat-shock proteins as molecular chaperones. Eur J Biochem 219: 11-23.
3. Benn SC, Perrelet D, Kato AC, Scholz J, Decosterd I, Mannion RJ, Bakowska JC, Woolf CJ. 2002. Hsp27 upregulation and phosphorylation is required for injured sensory and motor neuron survival. Neuron 36: 45-56.
4. Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E. 1993. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11: 153-163.
5. Bjorkdahl C, Sjogren MJ, Zhou X, Concha H, Avila J, Winblad B, Pei JJ. 2008. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments. J Neurosci Res 86: 1343-1352.
6. Borghi R, Piccini A, Delacourte A, Strocchi P, Zaccheo D, Tabaton M. 2004. Protein levels of glycogen synthase 3 kinase are normal in progressive supranuclear palsy. Neurosci Lett 366: 67-70.
7. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
8. Braak H, Braak E. 1995. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 16: 271-278; discussion278-284.
9. Bu B, Klunemann H, Suzuki K, Li J, Bird T, Jin LW, Vincent I. 2002. Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol Dis 11: 285-297.
10. Chen G, Liu C, Yao J, Jiang Q, Chen N, Huang H, Liang J, Li L, Lin L. 2010. Overweight, obesity, and their associations with insulin resistance and beta-cell function among Chinese: a cross-sectional study in China. Metabolism
11. Chen S, Brown IR. 2007. Neuronal expression of constitutive heat shock proteins: implications for neurodegenerative diseases. Cell Stress Chaperones 12: 51-58.
12. de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, Spires-Jones TL, Hyman BT. 2010. Caspase activation precedes and leads to tangles. Nature 464: 1201-1204.
13. Di Domenico F, Sultana R, Tiu GF, Scheff NN, Perluigi M, Cini C, Butterfield DA. 2010. Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease. Brain Res 1333: 72-81.
14. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, Ladurner G, Hell E, Strosberg AD, Patsch JR, Krempler F, Patsch W. 2001. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28: 178-183.
15. Feuillette S, Miguel L, Frebourg T, Campion D, Lecourtois M. 2010. Drosophila models of human tauopathies indicate that tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. J Neurochem 113: 895-903.
16. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K. 1993. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61: 921-927.
17. Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K. 1995. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 65: 732-738.
18. Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K. 2000. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 275: 5535-5544.
19. Gong CX, Liu F, Grundke-Iqbal I, Iqbal K. 2005. Post-translational modifications of tau protein in Alzheimer's disease. J Neural Transm 112: 813-838.
20. Greenberg SG, Davies P, Schein JD, Binder LI. 1992. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267: 564-569.
21. Gribble FM, Reimann F. 2003. Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions. J Diabetes Complications 17: 11-15.
22. Grimes CA, Jope RS. 2001. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65: 391-426.
23. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. 1986. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83: 4913-4917.
24. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH. 1992. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147: 58-62.
25. Havasi A, Li Z, Wang Z, Martin JL, Botla V, Ruchalski K, Schwartz JH, Borkan SC. 2008. Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J Biol Chem 283: 12305-12313.
26. Hirano A. 1992. Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam: immunohistochemical studies. Keio J Med 41: 6-9.
27. Hyman BT, Gomez-Isla T. 1994. Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging 15: 353-354; discussion 379-380.
28. Jinwal UK, O'Leary JC3rd, Borysov SI, Jones JR, Li Q, Koren J3rd, Abisambra JF, Vestal GD, Lawson LY, Johnson AG, Blair LJ, Jin Y, Miyata Y, Gestwicki JE, Dickey CA. 2010. Hsc70 rapidly engages tau after microtubule destabilization. J Biol Chem 285: 16798-16805.
29. Kovacs P, Ma L, Hanson RL, Franks P, Stumvoll M, Bogardus C, Baier LJ. 2005. Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians. Diabetologia 48: 2292-2295.
30. Kuo YC, Huang KY, Yang CH, Yang YS, Lee WY, Chiang CW. 2008. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol Chem 283: 1882-1892.
31. Leroy A, Landrieu I, Huvent I, Legrand D, Codeville B, Wieruszeski JM, Lippens G. 2010. Spectroscopic studies of GSK3β phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E. J Biol Chem (in press).
32. Liu R, Pei JJ, Wang XC, Zhou XW, Tian Q, Winblad B, Wang JZ. 2005. Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms. J Neurochem 94: 1225-1234.
33. Liu WK, Moore WT, Williams RT, Hall FL, Yen SH. 1993. Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease. J Neurosci Res 34: 371-376.
34. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J. 2001. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20: 27-39.
35. Morimoto RI, Kline MP, Bimston DN, Cotto JJ. 1997. The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem 32: 17-29.
36. Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM. 1993. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. Am J Pathol 143: 565-578.
37. Nemes Z, Devreese B, Steinert PM, Van Beeumen J, Fesus L. 2004. Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles. FASEB J 18: 1135-1137.
38. Pei JJ, Hugon J. 2008. mTOR-dependent signalling in Alzheimer's disease. J Cell Mol Med 12: 2525-2532.
39. Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I. 1997. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56: 70-78.
40. Pei JJ, Gong CX, Iqbal K, Grundke-Iqbal I, Wu QL, Winblad B, Cowburn RF. 1998. Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains. J Neural Transm 105: 69-83.
41. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF. 1999. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58: 1010-1019.
42. Pei JJ, Gong CX, An WL, Winblad B, Cowburn RF, Grundke-Iqbal I, Iqbal K. 2003. Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. Am J Pathol 163: 845-858.
43. Pei JJ, An WL, Zhou XW, Nishimura T, Norberg J, Benedikz E, Gotz J, Winblad B. 2006. P70 S6 kinase mediates tau phosphorylation and synthesis. FEBS Lett 580: 107-114.
44. Piao YS, Hayashi S, Wakabayashi K, Kakita A, Aida I, Yamada M, Takahashi H. 2002. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol 103: 469-474.
45. Renkawek K, Bosman GJ, de Jong WW. 1994. Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia. Acta Neuropathol 87: 511-519.
46. Sanchez C, Padilla R, Paciucci R, Zabala JC, Avila J. 1994. Binding of heat-shock protein 70 (hsp70) to tubulin. Arch Biochem Biophys 310: 428-432.
47. Schmidt EV, Christoph G, Zeller R, Leder P. 1990. The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol Cell Biol 10: 4406-4411.
48. Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM. 1999. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38: 3549-3558.
49. Schwarz L, Vollmer G, Richter-Landsberg C. 2010. The small heat shock protein HSP25/27 (HspB1) is abundant in cultured astrocytes and associated with astrocytic pathology in progressive supranuclear palsy and corticobasal degeneration. Int J Cell Biol 2010: 717520.
50. Shanavas A, Papasozomenos SC. 2000. tau kinases in the rat heat shock model: possible implications for Alzheimer disease. Proc Natl Acad Sci U S A 97: 14139-14144.
51. Shimura H, Miura-Shimura Y, Kosik KS. 2004. Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival. J Biol Chem 279: 17957-17962.
52. Sun H, Gong ZC, Yin JY, Liu HL, Liu YZ, Guo ZW, Zhou HH, Wu J, Liu ZQ. 2008. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with type 2 diabetes and rosiglitazone response in Chinese patients. Br J Clin Pharmacol 65: 917-926.
53. Tolstykh T, Lee J, Vafai S, Stock JB. 2000. Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. EMBO J 19: 5682-5691.
54. Toth ME, Gonda S, Vigh L, Santha M. 2010. Neuroprotective effect of small heat shock protein, Hsp27, after acute and chronic alcohol administration. Cell Stress Chaperones 15: 807-817.
55. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. 1975. A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72: 1858-1862.
56. Wilhelmus MM, Otte-Holler I, Wesseling P, de Waal RM, Boelens WC, Verbeek MM. 2006. Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains. Neuropathol Appl Neurobiol 32: 119-130.
57. Xie H, Litersky JM, Hartigan JA, Jope RS, Johnson GV. 1998. The interrelationship between selective tau phosphorylation and microtubule association. Brain Res 798: 173-183.
58. Zhang YJ, Xu YF, Liu YH, Yin J, Wang JZ. 2005. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation. FEBS Lett 579: 6230-6236.
59. Zhou XW, Li X, Bjorkdahl C, Sjogren MJ, Alafuzoff I, Soininen H, Grundke-Iqbal I, Iqbal K, Winblad B, Pei JJ. 2006. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains. Neurobiol Dis 22: 657-668.